ImmuneInvestigational

Thymopentin (TP-5)

Subcutaneous injection, Intramuscular injection

Overview

A synthetic pentapeptide (Arg-Lys-Asp-Val-Tyr) corresponding to residues 32-36 of thymopoietin, a thymic hormone involved in T-cell differentiation. Thymopentin stimulates early T-cell precursor differentiation and modulates mature T-cell function by enhancing IL-2 production and expression of T-cell surface markers.

Mechanism of Action

It partially restores immune function in immunocompromised states without the risks of whole thymic extracts..

Research Summary & Key Findings

Clinical trials showed improvements in T-cell subsets and function in primary immunodeficiency disorders and HIV infection. Approved in some countries as an immunomodulatory adjunct. Research demonstrated efficacy in reducing infection rates in immunosuppressed patients post-chemotherapy. Also investigated for rheumatoid arthritis and chronic hepatitis B with variable results.

Clinical Status

Investigational

Thymopentin (TP-5) is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

Subcutaneous injectionIntramuscular injection

Related Peptides in Immune

Find a Provider

Find a verified provider who offers Thymopentin (TP-5) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Thymopentin (TP-5).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.